Eledon Pharmaceuticals Inc
F:2TK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eledon Pharmaceuticals Inc
F:2TK
|
US |
Intrinsic Value
The intrinsic value of 
Eledon Pharmaceuticals Inc (2TK) under the Base Case is 1.53 EUR per share.
Compared with the current market price of 1.92 EUR, the stock appears
Overvalued by 20% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Eledon Pharmaceuticals Does
Eledon Pharmaceuticals is a clinical-stage drug company focused on medicines that calm the immune system. Its lead programs center on tegoprubart, an antibody designed to block a key immune signal called CD40L. The goal is to help patients who receive organ transplants or who live with autoimmune diseases by reducing harmful immune attacks without shutting the immune system down completely.
- Headquarters
- United States of America US
- Employees
- 33
- IPO date
- Sep 17, 2014
Revenue & Expenses Breakdown
Eledon Pharmaceuticals Inc
Earnings Waterfall
Eledon Pharmaceuticals Inc
The intrinsic value for Eledon Pharmaceuticals Inc (2TK) under the Base Case is 1.53 EUR.
Compared with the current market price of 1.92 EUR, the stock appears Overvalued by 20% .